Dr. Roderick McInnes, Director of the Lady Davis Institute at the JGH and Acting President of the Canadian Institutes of Health Research, is being honoured with the 2017 Distinguished Scientist Award by the Canadian Society for Clinical Investigation (CSCI).
Dr. McInnes, who holds the Alva Chair in Human Genetics and a Canada Research Chair in Neurogenetics at McGill University, is being recognized for significant and innovative contributions in the field of human genetics.
“The Distinguished Scientist Award is awarded to a Canadian medical doctor or medical scientist who has made significant contributions to new knowledge and is recognized in their field as expert, innovator, and as being in the forefront of research endeavours,” says Dr. Brian Bennett, Chair of the CSCI Awards Committee.
“Dr. McInnis has long been recognized for his leadership in Canadian basic and applied biomedical research. He is internationally renowned for his contributions to the molecular genetics of inherited metabolic disorders, to the molecular genetics of retinal and eye development, and to the genetic basis of retinal degenerative diseases.”
“It is a particular honour to receive the CSCI’s Distinguished Scientist Award because of the Society’s focus on the physician scientist, who plays such a crucial role in building the bridges between bench and bedside,” says Dr. McInnes. “The CSCI does so much to promote clinical research, which is the key to advancing medicine and improving health care.”
Dr. McInnes will receive the Award at the CSCI’s annual meeting in November in Toronto, where he will deliver a keynote address.